Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Connie P. Matthews
Observed names:
C P Matthews,
Connie Matthews
Observed institutions:
University of Washington,
Fred Hutch Cancer Center,
Beaumont Hospital, Royal Oak,
Frederick National Laboratory for Cancer Research,
National Cancer Institute,
Center for Cancer Research,
Massachusetts Institute of Technology
show all 7
OpenAlex ID:
A5084630481
Tumorigenesis Suppressor Pdcd4 Down-Regulates Mitogen-Activated Protein Kinase Kinase Kinase Kinase 1 Expression To Suppress Colon Carcinoma Cell Invasion
2006
·
Hsin-Sheng Yang
, Connie P. Matthews
, et al.
·
Molecular and Cellular Biology
·
202
Genetic and Epigenetic Changes in Human Epithelial Cells Immortalized by Telomerase
2000
·
D. Gregory Farwell
, Katherine A. Shera
, et al.
·
American Journal Of Pathology
·
196
PDF
AP-1 a Target for Cancer Prevention
2007
·
Connie Matthews
, Nancy Colburn
, et al.
·
Current Cancer Drug Targets
·
145
Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
2008
·
Qiou Wei
, Hong Jiang
, et al.
·
Proceedings of the National Academy of Sciences
·
85
Paraoxonase (Pon1) gene in mice: sequencing, chromosomal localization and developmental expression
1997
·
Wan-Fen Li
, Connie Matthews
, et al.
·
Pharmacogenetics
·
61
Genomic Changes and HPV Type in Cervical Carcinoma
2000
·
Connie P. Matthews
, Katherine A. Shera
, et al.
·
Proceedings of The Society for Experimental Biology and Medicine
·
53
Dominant-Negative Activator Protein 1 (TAM67) Targets Cyclooxygenase-2 and Osteopontin under Conditions in which It Specifically Inhibits Tumorigenesis
2007
·
Connie P. Matthews
, Alysia M. Birkholz
, et al.
·
Cancer Research
·
46
Generation and Characterization of Human Smooth Muscle Cell Lines Derived From Atherosclerotic Plaque
1999
·
Lisé R. Bonin
, Karen Madden
, et al.
·
Arteriosclerosis Thrombosis and Vascular Biology
·
43
Characterization of NR13-related human cell death regulator, Boo/Diva, in normal and cancer tissues
2001
·
Ruey-min Lee
, Jun Chen
, et al.
·
Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression
·
39
Growth Factors and Gene Expression of Stem Cells: Bone Marrow Compared With Peripheral Blood
2010
·
Dennis G. Smiler
, Muna Soltan
, et al.
·
Implant Dentistry
·
14
Genomic Changes and HPV Type in Cervical Carcinoma
2000
·
Connie P. Matthews
, Katherine A. Shera
, et al.
·
Proceedings of The Society for Experimental Biology and Medicine
·
11
Expression of truncated FHIT transcripts in cervical cancers and in normal human cells
2001
·
C P Matthews
, K Shera
, et al.
·
Oncogene
·
10
Supplementary Figures 1-3, Tables 1-2 from Dominant-Negative Activator Protein 1 (TAM67) Targets Cyclooxygenase-2 and Osteopontin under Conditions in which It Specifically Inhibits Tumorigenesis
2023
·
Connie P. Matthews
, Alysia M. Birkholz
, et al.
PDF
Data from Dominant-Negative Activator Protein 1 (TAM67) Targets Cyclooxygenase-2 and Osteopontin under Conditions in which It Specifically Inhibits Tumorigenesis
2023
·
Connie P. Matthews
, Alysia M. Birkholz
, et al.
Supplementary Legends - Figures 1-3, Tables 1-2 from Dominant-Negative Activator Protein 1 (TAM67) Targets Cyclooxygenase-2 and Osteopontin under Conditions in which It Specifically Inhibits Tumorigenesis
2023
·
Connie P. Matthews
, Alysia M. Birkholz
, et al.
PDF
Supplementary Figures 1-3, Tables 1-2 from Dominant-Negative Activator Protein 1 (TAM67) Targets Cyclooxygenase-2 and Osteopontin under Conditions in which It Specifically Inhibits Tumorigenesis
2023
·
Connie P. Matthews
, Alysia M. Birkholz
, et al.
Supplementary Legends - Figures 1-3, Tables 1-2 from Dominant-Negative Activator Protein 1 (TAM67) Targets Cyclooxygenase-2 and Osteopontin under Conditions in which It Specifically Inhibits Tumorigenesis
2023
·
Connie P. Matthews
, Alysia M. Birkholz
, et al.
Data from Dominant-Negative Activator Protein 1 (TAM67) Targets Cyclooxygenase-2 and Osteopontin under Conditions in which It Specifically Inhibits Tumorigenesis
2023
·
Connie P. Matthews
, Alysia M. Birkholz
, et al.
Genomic Changes and HPV Type in Cervical Carcinoma (44497)
2016
·
Connie P. Matthews
, Katherine A. Shera
, et al.
·
Proceedings of The Society for Experimental Biology and Medicine
Abstract B83: Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin tumors
2008
·
Qiou Wei
, Hong Jiang
, et al.
·
Cancer Prevention Research
Identification of dominant negative AP-1 (TAM67) target genes important for inhibition of tumorigenesis but not cell proliferation or survival.
2006
·
Connie P. Matthews
, Alysia M. Birkholz
, et al.
·
Cancer Epidemiology and Prevention Biomarkers
Show more works
View as search
Works count:
22
Citation count:
905
H-index:
11
I10-index:
12
Year
Topic
Type